URE-39 (Urea 39% Cream)

Manufacturer
SOLUTECH PHARMACEUTICALS LLC
Effective date
2018-03-14
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 20:25:32

Label at a glance#

ProductURE-39
Active ingredientUREA
Label structure12 sections

Indications and uses

For debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or prurient debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma, corns and calluses, as well as damaged, ingrown and dev...

Dosage and administration

Apply URE-39 Cream to affected skin two to three times per day as needed or as directed by a physician. Rub in until completely absorbed. Apply to diseased or damaged nail tissue two to three times per day or as directed by a physician. Best applied to affected areas immediately after showering and just before bedtime.

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx only

For external use only.

Not for ophthalmic use.

URE-39 Description

DESCRIPTION SECTION

URE-39 Cream is a potent keratolytic emollient which is a gentle, yet potent, tissue softener for skin and/or nails.

Each gram of URE-39 Cream contains:

ACTIVE: 39% Urea in a cream base of:

INACTIVES: Deionized Water, Carthamus Tinctorius (Safflower) Seed Oil, Emulsifying Wax, Glycerine, Propylene Glycol, Glyceryl Stearate, PEG 100 Stearate, Cetyl Alcohol, Dimethicone, C12/15 Alkyl Benzoate, Anthemis Nobilis (Chamomile) Flower Extract, Melaleuca Alternifolia (Tea Tree) Leaf Oil, Aloe Barbadensis Leaf, Phenoxyethanol, Methylparaben, Ethylparaben, Butylparaben, Propylparaben, and Isobutylparaben.

CHEMISTRY

SPL UNCLASSIFIED SECTION

Urea is a diamide of carbonic acid with the following chemical structure:

Chemical StructureChemical Structure

URE-39 - Clinical Pharmacology

CLINICAL PHARMACOLOGY SECTION

Urea gently dissolves the intercellular matrix which results in loosening the horny layer of skin and shedding scaly skin at regular intervals, thereby softening hyperkeratotic areas. Urea also hydrates and gently dissolves the intercellular matrix of the nail plate, which can result in the softening and eventual debridement of the nail plate.

PHARMACOKINETICS

PHARMACOKINETICS SECTION

The mechanism of action of topically applied Urea is not yet known.

INDICATIONS AND USES

INDICATIONS & USAGE SECTION

For debridement and promotion of normal healing of hyperkeratotic surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or prurient debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma, corns and calluses, as well as damaged, ingrown and devitalized nails.

Contraindications

CONTRAINDICATIONS SECTION

URE-39 Cream is contraindicated in patients with known hypersensitivity to any of the listed ingredients.

Warnings

WARNINGS SECTION

For external use only. Avoid contact with eyes, lips or mucous membranes. Do not use on areas of broken skin.

Precautions

PRECAUTIONS SECTION

Stop use and ask a doctor if redness or irritation develops. After applying this medication, wash hands and unaffected areas thoroughly. If swallowed, get medical help or contact Poison Control Center right away. KEEP THIS AND ALL MEDICATION OUT OF THE REACH OF CHILDREN.

PREGNANCY

PREGNANCY SECTION

Pregnancy Category B

SPL UNCLASSIFIED SECTION

Animal reproduction studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, URE-39 Cream should be given to a pregnant woman only if clearly needed.

NURSING MOTHERS

NURSING MOTHERS SECTION

It is not known whether or not this drug is secreted in human milk. Because many drugs are secreted in human milk, caution should be exercised when URE-39 Cream is administered to a nursing woman.

Adverse Reactions

ADVERSE REACTIONS SECTION

Transient stinging, burning, itching or irritation may occur and normally disappear on discontinuing the medication.

URE-39 - Dosage and Administration

DOSAGE & ADMINISTRATION SECTION

Apply URE-39 Cream to affected skin two to three times per day as needed or as directed by a physician. Rub in until completely absorbed. Apply to diseased or damaged nail tissue two to three times per day or as directed by a physician. Best applied to affected areas immediately after showering and just before bedtime.

How is URE-39 Supplied

HOW SUPPLIED SECTION

URE-39 (39% Urea Cream) is supplied in:

8oz (227gm) JarNDC: 70350-2612-1

STORAGE AND HANDLING SECTION

Store at 25°C (77°F); excursions permitted to 15°C - 30°C (59° - 86°F). Protect from freezing. [See USP Controlled Room Temperature.]

SPL UNCLASSIFIED SECTION

Manufactured for:
Solutech Pharmaceuticals LLC
Peoria, AZ 85345

Rx only

PRINCIPAL DISPLAY PANEL - 227 gm Jar Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 70350-2612-1

FOR TOPICAL USE ONLY

URE-39
UREA 39% CREAM

Smooth Easily Spreadable

Rx only

Solutech
PHARMACEUTICALS

Net WT.
8OZ (227 gm)

PRINCIPAL DISPLAY PANEL - 227 gm Jar Label
PRINCIPAL DISPLAY PANEL - 227 gm Jar Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1093289urea 39 % Topical CreamPSN1
1093289urea 390 MG/ML Topical CreamSCD1
1093289urea 39 % Topical CreamSY1

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70350-2612-12020-01-31C16284748780-19d75b9d1-1932-f424-e053-dadaa90a57ceURE-39 (Urea 39% Cream)

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
70350-2612-1URE-39227 g in 1 JARCREAM2271

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70350-2612URE-39 (UREA) CREAM [SOLUTECH PHARMACEUTICALS LLC]1Legacy NDC, 1 package rows20180317_ecf5d277-b1f6-495f-9f08-204217bef84e.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70350-2612-1GM - Gram70350-2612ddd696b5-1d0f-4c71-b00d-274a9955e04b12018-04-19

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
70350-261270350-2612-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 19 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
d11226bd-6486-4a59-bb3b-831df2e4b4bfecf5d277-b1f6-495f-9f08-204217bef84e2018-03-14Warnings, Adverse reactionsExact identifier
spl id: d11226bd-6486-4a59-bb3b-831df2e4b4bf
spl set id: ecf5d277-b1f6-495f-9f08-204217bef84e

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.